» Articles » PMID: 38819166

Anaerobes in Diabetic Foot Infections: Pathophysiology, Epidemiology, Virulence, and Management

Overview
Specialty Microbiology
Date 2024 May 31
PMID 38819166
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic foot infections (DFI) are a public health problem worldwide. DFI are polymicrobial, biofilm-associated infections involving complex bacterial communities organized in functional equivalent pathogroups, all including anaerobes. Indeed, multiple pathophysiological factors favor the growth of anaerobes in this context. However, the prevalence, role, and contribution of anaerobes in wound evolution remain poorly characterized due to their challenging detection. Studies based on culture reviewed herein showed a weighted average of 17% of patients with anaerobes. Comparatively, the weighted average of patients with anaerobes identified by 16S rRNA gene sequencing was 83.8%. Culture largely underestimated not only the presence but also the diversity of anaerobes compared with cultivation-independent approaches but both methods showed that anaerobic Gram-negative bacilli and Gram-positive cocci were the most commonly identified in DFI. Anaerobes were more present in deeper lesions, and their detection was associated with fever, malodorous lesions, and ulcer depth and duration. More specifically, initial abundance of spp. was associated with ulcer-impaired healing, spp. detection was significantly correlated with the duration of DFI, and the presence of spp. was significantly associated with amputation. Antimicrobial resistance of anaerobes in DFI remains slightly studied and warrants more consideration in the context of increasing resistance of the most frequently identified anaerobes in DFI. The high rate of patients with DFI-involving anaerobes, the increased knowledge on the species identified, their virulence factors, and their potential role in wound evolution support recommendations combining debridement and antibiotic therapy effective on anaerobes in moderate and severe DFI.

Citing Articles

The healing process of diabetic ulcers correlates with changes in the cutaneous microbiota.

Bruni E, Scaglione G, Tampone D, Primerano A, Bartolini B, Tenoglio C Sci Rep. 2024; 14(1):27628.

PMID: 39528566 PMC: 11554885. DOI: 10.1038/s41598-024-77987-2.


Integrating bioinformatics and multiple machine learning to identify mitophagy-related targets for the diagnosis and treatment of diabetic foot ulcers: evidence from transcriptome analysis and drug docking.

Guo H, Xiao K, Zheng Y, Zong J Front Mol Biosci. 2024; 11:1420136.

PMID: 39044840 PMC: 11263085. DOI: 10.3389/fmolb.2024.1420136.

References
1.
Esposito S, Leone S, Noviello S, Fiore M, Ianniello F, Felaco F . Foot infections in diabetes (DFIs) in the out-patient setting: an Italian multicentre observational survey. Diabet Med. 2008; 25(8):979-84. DOI: 10.1111/j.1464-5491.2008.02507.x. View

2.
Steffen E, Hentges D . Hydrolytic enzymes of anaerobic bacteria isolated from human infections. J Clin Microbiol. 1981; 14(2):153-6. PMC: 271925. DOI: 10.1128/jcm.14.2.153-156.1981. View

3.
Rastogi A, Sukumar S, Hajela A, Mukherjee S, Dutta P, Bhadada S . The microbiology of diabetic foot infections in patients recently treated with antibiotic therapy: A prospective study from India. J Diabetes Complications. 2016; 31(2):407-412. DOI: 10.1016/j.jdiacomp.2016.11.001. View

4.
Periasamy S, Kolenbrander P . Aggregatibacter actinomycetemcomitans builds mutualistic biofilm communities with Fusobacterium nucleatum and Veillonella species in saliva. Infect Immun. 2009; 77(9):3542-51. PMC: 2738031. DOI: 10.1128/IAI.00345-09. View

5.
Tascini C, Piaggesi A, Tagliaferri E, Iacopi E, Fondelli S, Tedeschi A . Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapy. Diabetes Res Clin Pract. 2011; 94(1):133-9. DOI: 10.1016/j.diabres.2011.07.017. View